Public market insider buying at IM Cannabis (IMCC)

Public market insider buying at IM Cannabis (C:IMCC)

Oren Shuster, CEO and Director, acquired 150,000 Common Shares on a direct ownership basis at prices ranging from US$2.188 to US$2.350 between April 5th, 2022 and April 8th, 2022. This represents a $420,709 investment into the company's shares and an account share holdings change of 1.6%.

IM Cannabis is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

IM Cannabis Corp. is a Canada-based medical cannabis company. The Company operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), where it cultivates, imports and distributes cannabis to medical patients, data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers and logistical hubs in Israel. The Company operates in Germany through Adjupharm GmbH (Adjupharm), where it is a certified medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses. The Company operates in Canada through Trichome JWC Acquisition Corp. d/b/a JWC and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.